Author/Creator: Li, Chonghua - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Li, Chonghua

1. Clinical drug‐drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P‐glycoprotein. (27th August 2014)

Authors:: Robertson, Sarah M.; Luo, Xia; Dubey, Neeraj; Li, Chonghua; Chavan, Ajit B.; Gilmartin, Geoffrey S.; Higgins, Mark; Mahnke, Lisa
Journal:: Journal of clinical pharmacology
Issue:: Volume 55:Number 1(2015:Jan.)
Page Start:: 56
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Contrasting detoxification mechanisms of Chlamydomonas reinhardtii under Cd and Pb stress. (July 2021)

Authors:: Li, Chonghua; Zheng, Chao; Fu, Hongxuan; Zhai, Suhua; Hu, Fan; Naveed, Sadiq; Zhang, Chunhua; Ge, Ying
Journal:: Chemosphere
Issue:: Volume 274(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Microalgal extracellular polymeric substances and their interactions with metal(loid)s: A review. Issue 19 (2nd October 2019)

Authors:: Naveed, Sadiq; Li, Chonghua; Lu, Xinda; Chen, Shuangshuang; Yin, Bin; Zhang, Chunhua; Ge, Ying
Journal:: Critical reviews in environmental science and technology
Issue:: Volume 49:Issue 19(2019)
Page Start:: 1769
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetic and Drug–Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor. Issue 3 (29th January 2019)

Authors:: Garg, Varun; Shen, Jinshan; Li, Chonghua; Agarwal, Sagar; Gebre, Asfiha; Robertson, Sarah; Huang, Jiayin; Han, Linda; Jiang, Licong; Stephan, Kristin; Wang, Linda T.; Lekstrom‐Himes, Julie
Journal:: Clinical and translational science
Issue:: Volume 12:Issue 3(2019)
Page Start:: 267
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2–5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study. Issue 4 (April 2019)

Authors:: McNamara, John J; McColley, Susanna A; Marigowda, Gautham; Liu, Fang; Tian, Simon; Owen, Caroline A; Stiles, David; Li, Chonghua; Waltz, David; Wang, Linda T; Sawicki, Gregory S
Journal:: Lancet
Issue:: Volume 7:Issue 4(2019)
Page Start:: 325
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗